Jennifer Goldsmith, senior vice president of Veeva Vault, examines why industry collaboration holds the key to faster clinical trials
Better together
As the clinical trial landscape becomes increasingly complex, the life sciences industry is supporting broad collaborations to define and implement common approaches that make running a trial easier. These collaborations are becoming a strategic priority for many companies hoping to create greater efficiencies in the race to deliver innovative therapies, drugs and medicines to market.